Navigationsweiche Anfang

Navigationsweiche Ende

 

(85) E. Marbach-Breitrück, L. Kutzner, M. Rothe, R. Gurke, Y. Schreiber, P. Reddanna, N. H. Schebb, S. Stehling, L. Wieler, D. Heydeck, H. Kuhn (2019) Functional characterization of knock-in mice expressing a 12/15-lipoxygenating ALOX5 mutant instead of the 5-lipoxygenating wildetype enzyme. Antioxid Redos Signa., doi.org/10.1089

abstract

(84) T. Greupner, E. Koch, L. Kutzner, A. Hahn, N.H. Schebb, J. P. Schuchardt (2019) Single-dose SDA-rich Echium oil increases plasma EPA, DPAn3 and DHA concentrations. Nutrients, 11, 2346

pdf

(83) K.M. Rund, S. Peng, R. Greite, C. Claaßen, F. Nolte, J.-M. Galano, L. Balas, T. Durand, R. Chen, F. Guele, N. H Schebb (2019) Dietary omega-3 PUFA improved tubular function after ischemia induced acute kidney injury in mice but did not attenuate impairment of renal function. Prostag Oth Lipid M.

abstract

(82) P. Waindok, E. Janecek-Erfurth, D. Lindenwald,  E. Wilk, K. Schughart, R. Geffers, J.-M. Galano, L. Balas, T. Durand, K.M. Rund, N. H. Schebb, C. Strube (2019) Multiplex profiling of inflammation-related bioactive lipid mediators in Toxocara canis- and T. cati-induced neurotoxocarosis. PLOS Neglected Tropical Diseases, A

pdf

(81) A. I. Ostermann, E. Koch, K. M. Rund, L. Kutzner, M. Mainka, N. H. Schebb (2019) Targeting Esterified Oxylipins by LC-MS – Effect of Sample Preparation on Oxylipin Pattern. Prostag Oth Lipid M. doi.org/10.1016/j.prostagglandins.2019.106384

abstract

(80) T. Zhou, B. Ringbeck, N. H. Schebb, J. Scherkenbeck (2019) Isolation, Total Synthesis and Quantification of Caffeoylisocitric Acid, a Characteristic Ingredient of the Superfood Amaranth. Tetrahedron, 75(33), 4479-4485.

abstract

(79) N. M. Hartung, J. Fischer, A. I.Ostermann, K. M. Rund, N. H. Schebb, U. Garscha (2019) Impact of food polyphenols on oxylipin biosynthesis in human neutrophils. BBA Lipids, 1864 (10), 536-1544.

abstract

(78) C. Gladine, A.I. Ostermann, J.W. Newman, N. H. Schebb (2019) MS-based targeted metabolomics of eicosanoids and other oxylipins: analytical and inter-individual variabilities. Free Radical Biology & Medicine, doi.org/10.1016/j.freeradbiomed.2019.05.012

abstract

(77) S. Tewes, F. Gueler, M. Gutberlet, N. H. Schebb, K. Rund, J.T. Kielstein, V.D. VoChieu, S. Rauhut, H. Haller, F. Wacker, K. Hueper (2019) Single-dose diclofenac in healthy volunteers can cause decrease in renal perfusion measured by functional magnetic resonance imaging. J. Pharm. Pharmacol. 71(8), 1262-1270.

abstract

(76) K.M. Rund, D. Heylmann, N. Seiwert, S. Wecklein, C. Oger, J.-M. Galano, T. Durand, R. Chen, F. Gueler, J. Fahrer, J. Bornhorst, N. H. Schebb (2019) Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress. Prostag Oth Lipid M. 10.1016/j.prostaglandins.2019.04.004.

abstract

(75) L. Kutzner, K. M. Rund, A. I. Ostermann, N. M. Hartung, J.-M. Galano, L. Balas, T. Durand, M. S. Balzer, S. David, N. H. Schebb (2019) Development of an optimized LC-MS method for the detection of specialized pro-resolving mediators in biological samples. Front. Pharmacol. 10:169.

pdf

(74) N. M. Hartung, M. Mainka, N. Kampschulte, A. I. Ostermanna, N. H. Schebb (2019) A strategy for validating concentrations of oxylipin standards for external calibration. Prostag Oth Lipid M, 141, 22-24.

abstract

(73) K.H. Weylandt, C. Schmöcker , A. Ostermann, L. Kutzner, I. Willenberg S. Kiesler , E. Steinhagen-Thiessen, N. H. Schebb, U. Kassner (2019) Activation of lipid mediator formation due to lipoprotein apheresis. Nutrients, Nutrients 2019, 11(2), 363.

pdf

(72) A. I. Ostermann, A. L. West, K. Schoenfeld, L. M. Browning, C. G. Walker, S. A. Jebb, P. C. Calder, N. H. Schebb (2019) Plasma oxylipins respond in a linear dose-response manner with increased intake of eicosapentaenoic and docosahexaeanoic acids: results from a randomized controlled trial in healthy humans. Am J Clin Nutr 2019;109:1–13.

abstract

(71) L. Paloque, T. Perez-Berezo, A. Abot, J. Dalloux-Chioccioli, S. Bourgeade-Delmas, P. Le Faouder, J. Pujo, M.-A. Teste, J.-M. François, N. H. Schebb, M. Mainka, C. Rolland, C. Blanpied, G. Dietrich, J. Bertrand-Michel, C. Deraison, A. Valentin, N. Cenac (2019) Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interaction. J Lipid Res, doi: 10.1194/jlr.M091736.

abstract

 

2018

(70) A. I. Ostermann T. Greupner, L. Kutzner, N. M. Hartung, A. Hahn, J. P. Schuchardt, N. H. Schebb (2018) Intra-individual variance of human plasma oxylipin pattern: Low inter-day variability in fastened blood samples versus high variability during the day. Anal Methods, 10, 4935 – 4944

pdf

(69) C. Dalle, A. I. Ostermann, T. Konrad, C. Coudy-Gandilhon, A. Decourt, J. C. Barthélémy , F. Roche, L. Féasson, A. Mazur, D. Béchet, N. H. Schebb, C. Gladine (2018) Muscle loss associated changes of oxylipin signatures during biological aging: an exploratory study from the PROOF cohort. The Journal of Gerontology, doi: 10.1093/gerona/gly187.

abstract

(68) T. Greupner, L. Kutzner, S. Pagenkopf, H. Kohrs, A. Hahn, N. H. Schebb, J. P. Schuchardt (2018) Effects of a low and a high dietary LA/ALA ratio on long-chain PUFA concentrations in red blood cells. Food & Function, 19, 4742-4752.

pdf

(67) H. Gottschall, C. Schmöcker, D. Hartmann, N. Rohwer, K. Rund, L. Kutzner, F. Nolte, A. I. Ostermann, N. H. Schebb, K. H. Weylandt (2018) Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue. J Lipid Res 59(5), 864-871.

pdf

(66) T. Greupner, L. Kutzner, F. Nolte, A. Strangmann, H. Kohrs, A. Hahn; N. H. Schebb, J.P. Schuchardt (2018) Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status. Food & Function 9(3), 1587-1600

pdf

(65) C. Schmöcker, I. W. Zhang, S. Kiesler, U. Kassner, A. I. Ostermann, E. Steinhagen-Thiessen, N. H. Schebb, K. H. Weylandt (2018) Effect of omega-3 fatty acid supplementation on oxylipins in a routine clinical setting. Int Mol Sci 19(1) 180-185.

abstract

(64) K. M. Rund, A. I. Ostermann, L. Kutzner, J.-M. Galano, C. Oger, C. Vigor; S. Wecklein, N. Seiwert, T. Durand, N. H. Schebb (2018) Development of an LC-(ESI-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs. Anal Chim Acta, 1037, 63-74.

abstract

 
2017

(63) A. I. Ostermann, P. Waindok, M. J. Schmidt, C. Y. Chiu, C. Smyl, N. Rohwer, K. H. Weylandt, N. H. Schebb (2017) Modulation of the Endogenous Omega-3 Fatty Acid and Oxylipin Profile in vivo – A Comparison of the fat-1 Transgenic Mouse with C57BL/6 Wildtype Mice on an Omega-3 Fatty Acid Enriched Diet. PLOS-1. doi.org/10.1371/journal.pone.0184470.

pdf

(62) C. Schmöcker, U. Kassner, A. I. Ostermann, S. Kiesler, E. Steinhagen-Thiessen, N. H. Schebb, K. H. Weylandt (2017) Effect of different lipid apheresis methods on plasma polyunsaturated fatty acids. Atherosclerosis-supplements, 30, 193-199.

abstract

(61) J. P. Schuchardt, A. I. Ostermann, L. Stork, S. Fritsch, H. Kohrs, T. Greupner, A. Hahn, N. H. Schebb (2017) Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood. Prostag Leukotr Ess, 121, 76-87.

abstract

(60) A.-C. Becker, I. Willenberg, A. Springer, N. H. Schebb, P. Steinberg, C. Strube (2017) Fatty acid composition of free-living and parasitic stages of the bovine lungworm Dictyocaulus viviparus Molecular & Biochemical Parasitology, 216, 39-44.

abstract

(59) A. I. Ostermann, N. H. Schebb (2017) Effects of Omega-3 Fatty Acid Supplementation on the Pattern of Oxylipins – A short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids. Food & Function, 8, 2355-2367.

pdf

(58) A. I. Ostermann, M. Reutzel, N. Hartung, N. Franke, L. Kutzner, K. Schoenfeld, K. H. Weylandt, G. P. Eckert , N. H. Schebb (2017) A Diet Rich in Omega-3 Fatty Acids Enhances Expression of Soluble Epoxide Hydrolase in Murine Brain. Prostag Oth Lipid M., 133, 79-87.

abstract

(57) L. Kutzner, K. Goloshchapova, S. Stehling, Dagmar Heydeck, H. Kuhn, N. H. Schebb (2017) Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexanoic acid BBA Lipids, 7, 666–675

abstract

(56) S. W. Meckelmann, S. Hellhake, M. Steuck, M. Krohn, N. H. Schebb (2017) Comparison of derivatization/ionization techniques for liquid chromatography tandem mass spectrometry analysis of oxylipins. Prostag Oth Lipid M 130, 1-8.

abstract

(55) L. Kutzner, A. I. Ostermann, T. Konrad, D. Riegel, J. P. Schuchardt, N. H. Schebb (2017) Lipid class specific quantitative analysis of n3-polyunsaturated fatty acid in food supplements. Agric Food Chem, 65, 139-147.

abstract

(54) S. Wang, I. Willenberg, M. Krohn, T. Hecker, S. Meckelmann, C. Li, Y. Pan, N. H. Schebb, P. Steinberg, M. T. Empl (2017) Growth-inhibiting activity of resveratrol imine analogs on tumor cells in vitro. PLOS-1, doi.org/10.1371/journal.pone.017050.

pdf


2016

(53) M. Steuck, S. Hellhake, N. H. Schebb (2016) Food Polyphenol Apigenin Inhibits the Cytochrome P450 Monoxygenase Branch of the Arachidonic Acid Cascade. J Agric Food Chem, 64, 8973-8976

abstract

(52) J. P. Schuchardt, A. I. Ostermann, L. Stork, L. Kutzner, H. Kohrs, T. Greupner, A. Hahn, N. H. Schebb (2016) Effects of docosahexaenoic acid supplementation on PUFA levels in red blood cells and plasma. Prostag Leukotr Ess, 115, 12-23.

abstract

(51) I. Willenberg, S. Rong, N. Shushakova, F. Gueler and N. H. Schebb (2016) Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis. Inflamm Res. 65, 133-142.

abstract

(50) K. Moeller, A. I. Ostermann , K. Rund , S. Thoms , C. Blume , F. Stahl , A. Hahn, N. H. Schebb, J. P. Schuchardt (2016) Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects. Prostag Leukotr Ess, 106, 39-49.

abstract

(49) P. Nicken, A. v. Keutz, I. Willenberg, A. Ostermann, N. H. Schebb, O. Kershawb, S. Giovanninib, G. Breves and P. Steinberg (2016) Impact of dextran sulphate sodium-induced colitis on the intestinal transport of the colon carcinogen PhIP. Arch Toxicol.90(5), 1093-1102.

abstract

 

2015

(48) I. Willenberg, A. K. Meschede, F. Güler M. S. Jang, N. Shushakova and N. H. Schebb (2015) Food polyphenols fail to cause a biologically relevant reduction of COX-2 activity. PLOS-1, 10.1371/journal.pone.0139147.

pdf

(47) A. Haghikia, S. Jörg, A. Duscha, J. Berg, A. Manzel, A. Waschbisch, A. Hammer, D. Lee, C. May, N. Wilck, A. I. Ostermann, N. H. Schebb , D.A. Akkad, D.A. Grohme, M. Kleinewietfeld, J. Thöne, S. Demir, D. N. Müller , R. Gold, R. A. Linker (2015) Dietary fatty acids directly impact CNS autoimmunity via the small intestine. Immunity, 43 (4), 817-829.

abstract

(46) I. Willenberg, M. Michael, J. Wonik and N. H. Schebb (2015) Investigation of the effects of soluble fibers on the absorption of resveratrol and of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PHIP) in the Caco-2 cellular model of intestinal absorption. Int J Food Sci Nutr, 66, 677-679.

abstract

(45) A. I. Ostermann, J. Herbers, I. Willenberg, R. Chen, S. H. Hwang, R. Greite, C. Morisseau, F. Gueler, B. D. Hammock and N. H. Schebb (2015) Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Prostag Oth Lipid M, 121A, 131-137.

abstract

(44) I. Willenberg, A. I. Ostermann, O. Kershawb, S. Giovanninib, A. v. Keutz, P. Steinberg and N. H. Schebb (2015) Effect of acute and chronic DSS induced colitis on plasma eicosanoid and oxylipin levels in the rat. Prostag Oth Lipid M, 120, 155-160.

abstract

(43) I. Willenberg, A. K. Meschede and N. H. Schebb (2015) Determining COX-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E2, D2 and thromboxane B2. J Chromatogr A 1391, 40-48.

abstract

(42) P. Nicken, A. v. Keutz, I. Willenberg, L. v. Elsner, G. Hamscher, L. Vanhaecke, B. Schröder, G. Breves, N. H. Schebb and P. Steinberg (2015) Intestinal absorption and cell transforming potential of PhIP-M1, a bacterial metabolite of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Toxicology Letters, 234, 92-98.

abstract

(41) I. Willenberg, A. I. Ostermann and N. H. Schebb (2015) Targeted metabolomics of the arachidonic acid cascade – Current state and challenges of LC-MS analysis of oxylipins. Anal Bioanal Chem, 407, 2675–2683.

abstract

(40) I. Willenberg, L. v. Elsner, P. Steinberg and N. H. Schebb (2015) Development of an online-SPE-LC-MS method for the investigation of the intestinal absorption of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PHIP) and its bacterial metabolite PHIP-M1 in a Caco-2 Transwell system. Food Chem. 166, 537–543.

abstract

(39) A. I. Ostermann, I. Willenberg and N. H. Schebb (2015) Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS. Anal Bioanal Chem, 407(5),1403-1414.

abstract

preprint, pdf

(38) I. Willenberg, M. Michael, J. Wonik, L. C. Bartel, M. T. Empl and N. H. Schebb (2015) Investigation of the absorption of resveratrol oligomers in the Caco-2 cellular model of intestinal absorption. Food Chem. 167, 245–250.

abstract

(37) A. I. Ostermann, I. Willenberg, K. W. Weylandt and N. H. Schebb (2015) Development of an online-SPE-LC-MS/MS method for 26 hydroxylated polyunsaturated fatty acids as rapid targeted metabolomics approach for the LOX, CYP and autoxidation pathways of the arachidonic acid cascade. Chromatographia, 78(5), 415-428.

abstract

(36) M. T. Empl, P. Kammeyer, R. Ulrich, J. F. Joseph, M. K. Parr, I. Willenberg, N. H. Schebb, W. Baumgärtner, E. Röhrdanz, C. Steffen and P. Steinberg (2015) The influence of chronic L-carnitine on the formation of preneoplastic and atherosclerotic lesions in the colon and aorta of male F-344 rats. Arch Toxicol. 89, 2079-2087.

abstract

(35) R. Maul, B. Warth, N.H. Schebb, R. Krska, M. Koch and M. Sulyok (2015) In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes. Arch Toxicol. 89, 949-960.

abstract

2014

(34) A. I. Ostermann, M. Müller, I. Willenberg and N. H. Schebb (2014) Determining the fatty acid composition in plasma and tissues as fatty acid methyl esters by gas chromatography – A comparison of different derivatization and extraction procedures. Prostag Leukotr Ess. 91, 235-241.

abstract

preprint, pdf

(33) N. H. Schebb, A. I. Ostermann, J. Yang, B. D. Hammock, A. Hahn and J. P. Schuchardt (2014) Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins. Prostag Oth Lipid M, 113-115, 21-29.

abstract

(32) J. P. Schuchardt, I. Schneider, I. Willenberg, J. Yang, B. D. Hammock, A. Hahn and N. H. Schebb (2014) Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA. Prostag Oth Lipid M. 109-111, 23-31.

abstract

(31) N. H. Schebb, J. B. Muvvala, D. Morin, A. R. Buckpitt, B. D. Hammock and R. H. Rice (2014) Metabolic activation of the antibacterial agent triclocarban by cytochrome P450 1A1 yielding glutathione adducts. Drug Metab Dispos. 42 (7),1098-1102.

abstract

(30) J. P. Schuchardt, S. Schmidt, G. Kressel, H. Dong, I. Willenberg, B. D. Hammock, A. Hahn and N. H. Schebb (2014) Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men. Prostag Leukotr Ess. 90, 27-37.

abstract

 

2013

(29) S. Stolte, S. Steudte, I. Willenberg, N. H. Schebb and P. Stepnowski (2013) Ecotoxicity of artificial sweeteners and stevioside. Environ Int. 60, 123-127.

abstract

(28) J. P. Schuchardt, S. Schmidt, G. Kressel, H. Dong, I. Willenberg, B. D. Hammock, A. Hahn and N. H. Schebb (2013) Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. Prostag Leukotr Ess. 89, 19-29.

abstract

(27) D. Falck, N. H. Schebb, S. Prihatiningtyas, J. Zhang, F. Heus, C. Morisseau, J. Kool, B. D. Hammock and W. M. A. Niessen (2013) Development of On-line Liquid Chromatography-Biochemical Detection for Soluble Epoxide Hydrolase Inhibitors in Mixtures. Chromatographia. 76, 13-21.

abstract

 

2012

(26) R. Maul, B. Warth, J. S. Kant, N. H. Schebb, R. Krska, M. Koch and M. Sulyok (2012) Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species. Chem ResTox. 25, 2715-2717

abstract

(25) G. Cherednichenko, R. Zhang, R. A. Bannister, V. Timofeyev, N. Li, E. B. Holland-Fritsch, W. Feng, G. C. Barrientos, N. H. Schebb, B. D. Hammock, K. G. Beam, N. Chiamvimonvat and I. N. Pessah (2012) Triclosan impairs excitation-contraction coupling and Ca2+ dynamics in striated muscle. Proc Natl Acad Sci U S A. 109 (35), 14158-14163.

pdf

(24) I. Willenberg, W. Brauer, M. T. Empl and N. H. Schebb (2012) Development of a rapid LC-UV Method for the Investigation of chemical and metabolic Stability of Resveratrol Oligomers. J Agric Food Chem. 60 (32), 7844-7850.

abstract

(23) B. Inceoglu, K. M. Wagner, J. Yang, A. Bettaieb, N. H. Schebb, S. H. Hwang, C. Morisseau, F. Haj and B. D. Hammock (2012) Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes. Proc Natl Acad Sci U S A. 109 (28), 11390-11395

pdf

(22) N. H. Schebb, B. Buchholz, B. D. Hammock and R. H. Rice (2012) Metabolism of the Antibacterial Triclocarban by Human Epidermal Keratinocytes to Yield Protein Adducts? J Biochem Mol Toxic. 26 (6), 230-234.

abstract

(21) A. Eißing, D. Fischer, A. Baumann, N. H. Schebb, U. Karst, K. Rose, S. Klumpp and J. Krieglstein (2012) Acetylcholine content and viability of cholinergic neurons are influenced by the activity of protein histidine phosphatase. BMC Neuroscience 13:31.

pdf

(20) C. Morisseau, N. H. Schebb, H. Dong, A. Ulu, P. A. Aronov and B. D. Hammock (2012) Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids. Biochem Bioph Res Co. 419 (4), 796-800.

pdf

(19) N. H. Schebb, K. C. Ahn, H. Dong, S. J. Gee and B. D. Hammock (2012) Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels. Chemosphere. 87 (7), 825-827

pdf

(18) K. C. Ahn, T. Kasagami, H. J. Tsai, N. H. Schebb, T. Ogunyoku, S. J. Gee, T. M. Young and B. D. Hammock (2012) An Immunoassay to Evaluate Human/Environmental Exposure to the Antimicrobial Triclocarban. Environ Sci Techno. 46 (1), 374-381.

pdf

(17) N. H. Schebb, B. Franze, R. Maul, A. Ranganathan and B. D. Hammock (2012) In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites. Drug Metab Dispos. 40 (1), 25-31.

abstract

 

2011

(16) N. H. Schebb, I. Flores, T. Kurobe, B. Franze, A. Ranganathan, B. D. Hammock and S. Teh (2011) Bioconcentration, Metabolism and Excretion of Triclocarban in Larval Qurt Medaka (Oryzias latipes). Aquat Toxicol. 105, 448-454.

pdf

(15) N. H. Schebb, M. Huby, S. H. Hwang, C. Morisseau, and B. D. Hammock (2011) Development of an Online-SPE-LC-MS Based Assay using Endogenous Substrate for Investigation of Soluble Epoxide Hydrolase (sEH) Inhibitors. Anal Bioanal Chem. 400 (5), 1359-1366.

pdf

(14) B. Inceoglu, K. Wagner, N. H. Schebb, C. Morisseau, S. L. Jinks, C. Hegedus, A. Ulu, R. Brosnan, A. L. Morrow and B. D. Hammock (2011) Epoxy-fatty acid produced antinociception is driven by pain and elevated cAMP. Proc Natl Acad Sci U S A. 108, (12), 5093-5097.

pdf

(13) N. H. Schebb, B. Inceoglu, K. C. Ahn, C. Morisseau, S. Gee and B. D. Hammock (2011) Investigation of human exposure to triclocarban after showering, and preliminary evaluation of its biological effects. Environ Sci Techno. 45 (7), 3109-3115.

pdf

(12) N. H. Schebb, B. Inceoglu, K. Wagner, T. Rose and B. D. Hammock (2011) Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies. Anal Methods. 3, 420-428.

pdf 

 

2010

(11) A. Baumann, W. Lohmann, T. Rose, K. C. Ahn, B. D. Hammock, U. Karst and N. H. Schebb (2010) Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban (TCC) metabolites. Drug Metab Dispos. 38, 2130-2138.

pdf

(10) M. Siemerink, N. H. Schebb, A. Liesener, M. Vogel, H. Hayen and U. Karst (2010) Development of a fast LCMS-based Screening-Method for Angiotensin-Converting-Enzyme (ACE)-Inhibitors in complex natural mixtures like snake venom. Rapid Commun Mass Spectrom. 24, 687-697.

abstract

(9) A. Braune, S. E. Kulling, R. Maul, N. H. Schebb and M. Blaut (2010) The red clover isoflavone irilone is largely resistant to degradation by the human gut microbiota. Mol Nutr Food Res. 54, 929-938.

abstract

 

2009

(8) N. H. Schebb, D. Falck, E-M. Hein, U. Karst and H. Hayen (2009) A fast LC-ESI-MS Method for Monitoring Phospholipase A2 Activity. J Chromatogr A. 1216, 5249-5255.

abstract

(7) N. H. Schebb, T. Vielhaber, A. Jousset and U. Karst (2009) Development of a Liquid Chromatography-Based Screening Methodology for Proteolytic Enzyme Activtiy. J Chromatogr A. 1216, 4407-4415.

abstract

(6) N. H. Schebb, H. Faber, R. Maul, F. Heus, J. Kool, H. Irth and U. Karst (2009) Analysis of Glutathione Adducts of Patulin by Means of Liquid Chromatography (HPLC) with Biochemical Detection (BCD) and Electrospray Ionization Tandem Mass Spectrometry (ESI-MS/MS). Anal Bioanal Chem. 394, 1361-1373.

abstract

 

2008

(5) N. H. Schebb, F. Heus, T. Saenger, H. Irth, U. Karst and J. Kool (2008) Development of a Countergradient Parking System for Gradient Liquid Chromatography with Online Biochemical Detection of Serine Protease Inhibitors. Anal Chem. 80 (17), 6764-6772.

abstract

(4) N. H. Schebb, D. Fischer, E-M. Hein, H. Hayen, J. Krieglstein, S. Klumpp and U. Karst (2008) Fast sample preparation and liquid chromatography-tandem mass spectrometry method for assaying cell lysate acetylcholine. J Chromatogr A. 1183, 100-107.

abstract

(3) R. Maul, N. H. Schebb and S. E. Kulling (2008) Application of LC and GC hyphenated with mass spectrometry as tool for characterization of unknown derivatives of isoflavonoids. Anal Bioanal Chem. 391, 239-250.

abstract

 

2007

(2) E. Pfeiffer, N. H. Schebb, J. Podlech and M. Metzler (2007) Novel oxidative in vitro metabolites of the mycotoxins alternariol and alternariol methyl ether. Mol Nutr Food Res. 51, 307-316.

abstract

(1) A. Liesener, A. M. Perchuc, R. Schöni, N. H. Schebb, M. Wilmer and U. Karst (2007) Screening of acetylcholinesterase inhibitors in snake venom by electrospray mass spectrometry. Pure Appl Chem. 79 (12), 2339-2349.

pdf